melatonin has been researched along with Menopause in 57 studies
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of our study is to search diagnostic tools for early detection of prenosological melatonin deficiency in postmenopausal women and women in menopausal transition with climacteric syndrome for establishment effective personalized prevention and treatment programs." | 7.91 | [Perimenopausal melatonin deficiency syndrome in system of personalized management of quality of life of women with climacteric syndrome.] ( Mamontova, AG; Soloviev, AG; Usoltseva, EN, 2019) |
| "Although studies have reported the effects of the menstrual cycle on melatonin rhythmicity, none has investigated the effects of menopause on the melatonin rhythm." | 7.73 | Effect of menopause on melatonin and alertness rhythms investigated in constant routine conditions. ( Ferns, GA; Hampton, SM; Skene, DJ; Walters, JF, 2005) |
| "Experimental data from animals suggest a protective role for the pineal hormone melatonin in the etiology of breast cancer, but results from the few retrospective case-control studies that examined the association in humans have been inconsistent." | 7.72 | Melatonin and breast cancer: a prospective study. ( Allen, DS; Fentiman, IS; Key, TJ; Travis, RC, 2004) |
| "Daytime plasma melatonin values were measured by radioimmune assay in 86 patients with breast cancer; 280 assays were done and compared with the clinical status of the patients." | 7.68 | Plasma melatonin in patients with breast cancer. ( Falkson, G; Falkson, HC; Meyer, BJ; Rapoport, BL; Steyn, ME, 1990) |
| "Morning levels of serum melatonin, FSH, LH, prolactin (PRL), progesterone and estradiol were studied by RIA during the ovarian cycle, perimenopause and menopause in 79 healthy women." | 7.68 | Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. ( Acuña, D; Fernandez, B; Malde, JL; Montero, A, 1990) |
| "We studied the 24-hour plasma melatonin profile in three groups of women: normal individuals, women with breast cancer, and women at high risk for breast cancer, to determine the relationship of plasma melatonin to this malignancy." | 7.67 | Plasma melatonin and the hormone-dependency of human breast cancer. ( Bagley, CS; Danforth, DN; Lippman, ME; Mulvihill, JJ; Tamarkin, L, 1985) |
| "Melatonin is a neurohormone secreted mainly by the pineal gland that controls circadian rhythm, which is primarily regulated by light." | 6.52 | Melatonin in aging women. ( Caglar, GS; Gursoy, AY; Kiseli, M, 2015) |
| "Patients with breast cancer undergoing lumpectomy had significantly disturbed sleep architecture the night after surgery, and these changes were normalised after 2 weeks." | 5.39 | Sleep disturbances and changes in urinary 6-sulphatoxymelatonin levels in patients with breast cancer undergoing lumpectomy. ( Gögenur, I; Hansen, MV; Madsen, MT; Rosenberg, J; Wildschiødtz, G, 2013) |
| "We used the search terms "melatonin" together with "menopause" or "post-menopause" or "peri-menopause" in multiple databases online including PubMed, Web of Science, Embase, Clinical trial, Cochrane Library, and China National Knowledge Infrastructure from the first publication year to October 2020." | 5.12 | Effects of exogenous melatonin on sleep quality and menopausal symptoms in menopausal women: a systematic review and meta-analysis of randomized controlled trials. ( Fang, X; Jiang, L; Wang, S; Wu, T; Yi, M; Zhang, X, 2021) |
| " Endogenous secretion of melatonin decreases with aging across genders, and, among women, menopause is associated with a significant reduction of melatonin levels, affecting sleep." | 4.93 | Circadian rhythm and menopause. ( Pines, A, 2016) |
| "The disparity between the rates of breast cancer in industrialized and less-industrialized regions has led to many hypotheses, including the theory that exposure to light-at-night and/or electromagnetic fields (EMF) may suppress melatonin and that reduced melatonin may increase the risk of breast cancer." | 4.80 | Industrialization, electromagnetic fields, and breast cancer risk. ( Kheifets, LI; Matkin, CC, 1999) |
| "The aim of our study is to search diagnostic tools for early detection of prenosological melatonin deficiency in postmenopausal women and women in menopausal transition with climacteric syndrome for establishment effective personalized prevention and treatment programs." | 3.91 | [Perimenopausal melatonin deficiency syndrome in system of personalized management of quality of life of women with climacteric syndrome.] ( Mamontova, AG; Soloviev, AG; Usoltseva, EN, 2019) |
| "Melatonin and progesterone levels decline during the perimenopause." | 3.80 | The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice. ( Alonso-Gonzalez, C; Bondi, CD; Clafshenkel, WP; Davis, VL; Dodda, BR; Kotlarczyk, MP; Sanchez-Barcelo, E; Witt-Enderby, PA, 2014) |
| "A protective role of melatonin in the etiology of breast cancer has been suggested." | 3.74 | Urinary 6-sulfatoxymelatonin and mammographic density in Japanese women. ( Fujita, H; Hara, T; Kashiki, Y; Matsubara, T; Nagao, Y; Nagata, C; Shibuya, C; Shimizu, H; Yamamoto, S, 2007) |
| "Although studies have reported the effects of the menstrual cycle on melatonin rhythmicity, none has investigated the effects of menopause on the melatonin rhythm." | 3.73 | Effect of menopause on melatonin and alertness rhythms investigated in constant routine conditions. ( Ferns, GA; Hampton, SM; Skene, DJ; Walters, JF, 2005) |
| "Experimental data from animals suggest a protective role for the pineal hormone melatonin in the etiology of breast cancer, but results from the few retrospective case-control studies that examined the association in humans have been inconsistent." | 3.72 | Melatonin and breast cancer: a prospective study. ( Allen, DS; Fentiman, IS; Key, TJ; Travis, RC, 2004) |
| "Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the normal nocturnal rise in melatonin." | 3.71 | Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. ( Chen, C; Davis, S; Kaune, WT; Mirick, DK; Stevens, RG, 2001) |
| "Daytime plasma melatonin values were measured by radioimmune assay in 86 patients with breast cancer; 280 assays were done and compared with the clinical status of the patients." | 3.68 | Plasma melatonin in patients with breast cancer. ( Falkson, G; Falkson, HC; Meyer, BJ; Rapoport, BL; Steyn, ME, 1990) |
| "We studied the 24-hour plasma melatonin profile in three groups of women: normal individuals, women with breast cancer, and women at high risk for breast cancer, to determine the relationship of plasma melatonin to this malignancy." | 3.67 | Plasma melatonin and the hormone-dependency of human breast cancer. ( Bagley, CS; Danforth, DN; Lippman, ME; Mulvihill, JJ; Tamarkin, L, 1985) |
| "The effect of melatonin on LH and FSH secretion in basal conditions and after stimulation with synthetic LHRH was studied in 3 volunteer normal men and 3 women two to five years after menopause." | 3.65 | Effect of melatonin on the basal and stimulated gonadotropin levels in normal men and postmenopausal women. ( Aparicio, NJ; Cramer, C; Debeljuk, L; Fideleff, H; Guitelman, A; Mancini, A, 1976) |
| "Melatonin treatment improves EEG patterns and subjective sleep quality in postmenopausal women with preexisting sleep impairment." | 2.72 | Melatonin and the health of menopausal women: A systematic review. ( Peleg, R; Treister-Goltzman, Y, 2021) |
| "a persistent condition of past insomnia and aging per se) increase the risk of insomnia during menopause." | 2.66 | Insomnia and menopause: a narrative review on mechanisms and treatments. ( Agostoni, EC; Campana, C; Marra, S; Nappi, RE; Nobili, L; Palagini, L; Proserpio, P, 2020) |
| "Melatonin is a neurohormone secreted mainly by the pineal gland that controls circadian rhythm, which is primarily regulated by light." | 2.52 | Melatonin in aging women. ( Caglar, GS; Gursoy, AY; Kiseli, M, 2015) |
| "Melatonin binding sites have been demonstrated in the central nervous system (mainly in the pars dystalis of the pituitary and hypothalamic suprachiasmatic nucleus) as well as in the reproductive organs, e." | 2.44 | [The influence of melatonin on human reproduction]. ( Boczek-Leszczyk, E; Juszczak, M, 2007) |
| "The same group is at higher risk of insomnia and depression." | 2.43 | Menopause related sleep disorders. ( Eichling, PS; Sahni, J, 2005) |
| "Melatonin profiles are a diagnostic tool to distinguish between several forms of depression, like major depression, winter depression (SAD), unipolar depression, delayed sleep phase syndrome (DSPS)." | 2.41 | Melatonin deficiencies in women. ( Herold, J; Rohr, UD, 2002) |
| "Menopause is associated with a reduction in melatonin which may relate to the changing gonadotropin levels." | 2.40 | Melatonin and human reproduction. ( Reiter, RJ, 1998) |
| "Younger age at menopause has been associated with increased risk of adverse health outcomes, particularly those linked to reproduction." | 1.51 | Rotating night shift work and menopausal age. ( Cotterchio, M; Eliassen, AH; Hankinson, SE; Knight, JA; Raboud, J; Rosner, B; Schernhammer, E; Stock, D; Strohmaier, S; Willett, W, 2019) |
| "The Asian women with TT-genotype and insomnia had a lower levels of melatonin as compared to control at daytime, evening and night." | 1.48 | Association of the melatonin circadian rhythms with clock 3111T/C gene polymorphism in Caucasian and Asian menopausal women with insomnia. ( Bairova, TA; Kolesnikova, LI; Madaeva, IM; Semenova, NV; Sholokhov, LF; Zhambalova, RM, 2018) |
| "Melatonin levels was measured in the saliva 4 times a day (06." | 1.48 | Association of 3111T/C Polymorphism of the Clock Gene with Circadian Rhythm of Melatonin in Menopausal Women with Insomnia. ( Bairova, TA; Kalyuzhnaya, OV; Kolesnikova, LI; Madaeva, IM; Rashidova, MA; Semenova, NV; Zhambalova, RM, 2018) |
| "Patients with breast cancer undergoing lumpectomy had significantly disturbed sleep architecture the night after surgery, and these changes were normalised after 2 weeks." | 1.39 | Sleep disturbances and changes in urinary 6-sulphatoxymelatonin levels in patients with breast cancer undergoing lumpectomy. ( Gögenur, I; Hansen, MV; Madsen, MT; Rosenberg, J; Wildschiødtz, G, 2013) |
| "Intrinsic skin aging is determined primarily by genetic factors and hormonal status." | 1.32 | [Intrinsic skin aging. A critical appraisal of the role of hormones]. ( Zouboulis, ChC, 2003) |
| "The melatonin measures were not consistently related to any of the previously reported hypothalamic-pituitary-adrenal cortical axis measures in these subjects." | 1.28 | Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. ( Hanada, K; Heist, EK; Lesser, IM; McGeoy, SS; Rubin, RT, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (14.04) | 18.7374 |
| 1990's | 8 (14.04) | 18.2507 |
| 2000's | 22 (38.60) | 29.6817 |
| 2010's | 13 (22.81) | 24.3611 |
| 2020's | 6 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Usoltseva, EN | 2 |
| Soloviev, AG | 2 |
| Mamontova, AG | 2 |
| Proserpio, P | 1 |
| Marra, S | 1 |
| Campana, C | 1 |
| Agostoni, EC | 1 |
| Palagini, L | 1 |
| Nobili, L | 1 |
| Nappi, RE | 1 |
| Laudisio, D | 1 |
| Barrea, L | 1 |
| Pugliese, G | 1 |
| Aprano, S | 1 |
| Castellucci, B | 1 |
| Savastano, S | 1 |
| Colao, A | 1 |
| Muscogiuri, G | 1 |
| Cipolla-Neto, J | 1 |
| Amaral, FG | 1 |
| Soares, JM | 1 |
| Gallo, CC | 1 |
| Furtado, A | 1 |
| Cavaco, JE | 1 |
| Gonçalves, I | 1 |
| Santos, CRA | 1 |
| Quintela, T | 1 |
| Yi, M | 1 |
| Wang, S | 1 |
| Wu, T | 1 |
| Zhang, X | 1 |
| Jiang, L | 1 |
| Fang, X | 1 |
| Treister-Goltzman, Y | 1 |
| Peleg, R | 1 |
| Semenova, NV | 2 |
| Madaeva, IM | 2 |
| Bairova, TA | 2 |
| Zhambalova, RM | 2 |
| Sholokhov, LF | 1 |
| Kolesnikova, LI | 2 |
| Kalyuzhnaya, OV | 1 |
| Rashidova, MA | 1 |
| Stock, D | 1 |
| Knight, JA | 1 |
| Raboud, J | 1 |
| Cotterchio, M | 1 |
| Strohmaier, S | 1 |
| Willett, W | 1 |
| Eliassen, AH | 1 |
| Rosner, B | 1 |
| Hankinson, SE | 2 |
| Schernhammer, E | 1 |
| Hansen, MV | 1 |
| Madsen, MT | 1 |
| Wildschiødtz, G | 1 |
| Rosenberg, J | 1 |
| Gögenur, I | 1 |
| Tamura, H | 1 |
| Takasaki, A | 1 |
| Taketani, T | 1 |
| Tanabe, M | 1 |
| Lee, L | 1 |
| Tamura, I | 1 |
| Maekawa, R | 1 |
| Aasada, H | 1 |
| Yamagata, Y | 1 |
| Sugino, N | 1 |
| Maria, S | 1 |
| Witt-Enderby, PA | 2 |
| Bondi, CD | 1 |
| Alonso-Gonzalez, C | 1 |
| Clafshenkel, WP | 1 |
| Kotlarczyk, MP | 1 |
| Dodda, BR | 1 |
| Sanchez-Barcelo, E | 1 |
| Davis, VL | 1 |
| Gursoy, AY | 1 |
| Kiseli, M | 1 |
| Caglar, GS | 1 |
| Pines, A | 1 |
| Cagnacci, A | 2 |
| D'Anna, R | 1 |
| Santamaria, A | 1 |
| Giorgianni, G | 1 |
| Vaiarelli, A | 1 |
| Gullo, G | 1 |
| Di Bari, F | 1 |
| Benvenga, S | 1 |
| Baeza, I | 1 |
| Alvarado, C | 1 |
| Alvarez, P | 1 |
| Salazar, V | 1 |
| Castillo, C | 1 |
| Ariznavarreta, C | 1 |
| Fdez-Tresguerres, JA | 1 |
| De la Fuente, M | 1 |
| Meliska, CJ | 3 |
| Martínez, LF | 2 |
| López, AM | 3 |
| Sorenson, DL | 2 |
| Nowakowski, S | 2 |
| Parry, BL | 4 |
| Zouboulis, ChC | 1 |
| Travis, RC | 1 |
| Allen, DS | 1 |
| Fentiman, IS | 1 |
| Key, TJ | 1 |
| Harrod, CG | 1 |
| Bendok, BR | 1 |
| Hunt Batjer, H | 1 |
| Walters, JF | 1 |
| Hampton, SM | 1 |
| Ferns, GA | 1 |
| Skene, DJ | 2 |
| Bellipanni, G | 2 |
| DI Marzo, F | 1 |
| Blasi, F | 1 |
| Di Marzo, A | 1 |
| Schernhammer, ES | 1 |
| Kroenke, CH | 1 |
| Dowsett, M | 1 |
| Folkerd, E | 1 |
| Fernando Martínez, L | 1 |
| Maurer, EL | 1 |
| Sorenson, D | 1 |
| Eichling, PS | 1 |
| Sahni, J | 1 |
| Nagata, C | 1 |
| Matsubara, T | 1 |
| Hara, T | 1 |
| Fujita, H | 1 |
| Nagao, Y | 1 |
| Yamamoto, S | 1 |
| Shibuya, C | 1 |
| Kashiki, Y | 1 |
| Shimizu, H | 1 |
| Hauger, RL | 1 |
| Elliott, JA | 1 |
| Boczek-Leszczyk, E | 1 |
| Juszczak, M | 1 |
| Markantonis, SL | 1 |
| Tsakalozou, E | 1 |
| Paraskeva, A | 1 |
| Staikou, C | 1 |
| Fassoulaki, A | 1 |
| Ivanov, SV | 1 |
| Mal'tseva, LI | 1 |
| Gafarova, EA | 1 |
| Garipova, GKh | 1 |
| Aleem, FA | 1 |
| Weitzman, ED | 1 |
| Weinberg, U | 1 |
| Tapp, E | 1 |
| Skinner, RG | 1 |
| Phillips, V | 1 |
| Bartsch, C | 1 |
| Seeger, H | 1 |
| Mück, AO | 1 |
| Lippert, TH | 1 |
| Reiter, RJ | 1 |
| Kheifets, LI | 1 |
| Matkin, CC | 1 |
| Sternon, J | 1 |
| Zanni, AL | 1 |
| Veneri, MG | 1 |
| Menozzi, R | 1 |
| Volpe, A | 1 |
| Rio, GD | 1 |
| Bianchi, P | 1 |
| Pierpaoli, W | 1 |
| Bulian, D | 1 |
| Ilyia, E | 1 |
| Oosthuizen, GM | 1 |
| Joubert, G | 1 |
| du Toit, RS | 1 |
| Davis, S | 1 |
| Kaune, WT | 1 |
| Mirick, DK | 1 |
| Chen, C | 1 |
| Stevens, RG | 1 |
| Newton, RP | 1 |
| Rohr, UD | 1 |
| Herold, J | 1 |
| Adami, HO | 1 |
| Rimsten, A | 1 |
| Wide, L | 1 |
| Wetterberg, L | 1 |
| Halberg, F | 1 |
| Tarquini, B | 1 |
| Cagnoni, M | 1 |
| Haus, E | 1 |
| Griffith, K | 1 |
| Kawasaki, T | 1 |
| Wallach, LA | 1 |
| Ueno, M | 1 |
| Uezo, K | 1 |
| Matsuoka, M | 1 |
| Kuzel, M | 1 |
| Halberg, E | 1 |
| Omae, T | 1 |
| Fideleff, H | 1 |
| Aparicio, NJ | 1 |
| Guitelman, A | 1 |
| Debeljuk, L | 1 |
| Mancini, A | 1 |
| Cramer, C | 1 |
| Netter, A | 1 |
| Gayral, MN | 1 |
| Millet, D | 1 |
| Rubin, RT | 1 |
| Heist, EK | 1 |
| McGeoy, SS | 1 |
| Hanada, K | 1 |
| Lesser, IM | 1 |
| Falkson, G | 1 |
| Falkson, HC | 1 |
| Steyn, ME | 1 |
| Rapoport, BL | 1 |
| Meyer, BJ | 1 |
| Fernandez, B | 1 |
| Malde, JL | 1 |
| Montero, A | 1 |
| Acuña, D | 1 |
| Bojkowski, CJ | 1 |
| Currie, JE | 1 |
| Wright, J | 1 |
| Boulter, PS | 1 |
| Arendt, J | 1 |
| Danforth, DN | 1 |
| Tamarkin, L | 1 |
| Mulvihill, JJ | 1 |
| Bagley, CS | 1 |
| Lippman, ME | 1 |
| Grishchenko, VI | 1 |
| Zubkov, GV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Is Dietary Melatonin Supplementation a Viable Adjunctive Therapy for Chronic Periodontitis? A Preliminary Randomized Clinical Trial.[NCT03368430] | Phase 4 | 74 participants (Actual) | Interventional | 2016-07-04 | Completed | ||
| Assessment and Augmentation of Lip Appearance in Specific Study Populations[NCT04839692] | Phase 4 | 37 participants (Actual) | Interventional | 2021-05-07 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Pre and post-treatment lip vessel thickness was measured in µm using Optical Coherence Tomography-Angiography imaging. For each age group, pre and post-treatment means were calculated.~The difference between the post and the pre-treatment means is shown below (post-treatment mean - pre-treatment mean)." (NCT04839692)
Timeframe: Day 1 and Day 14
| Intervention | µm (Mean) |
|---|---|
| Young Females (21-30 Years Old) | 0.833 |
| Post Menopausal Females | 0.360 |
"The Lip Fullness Grading Scale was used to measure the size of the lips before and after the procedure in both groups. The result presented below is the difference between the means after and before the procedures for each group.~min value: 0 - very thin lips - worse outcome Max value: 4 - full lips- a better outcome" (NCT04839692)
Timeframe: D1 and D14
| Intervention | units on a scale (Mean) |
|---|---|
| Young Females (21-30 Years Old) | 1.14 |
| Post Menopausal Females | 0.78 |
This scale will be used to record the subject's overall pain from the procedure. There are 6 faces ranging from 0=no pain to 10=the worst pain. (NCT04839692)
Timeframe: Day 1
| Intervention | score on a scale (Mean) |
|---|---|
| Young Females (21-30 Years Old) | 2.9 |
| Post Menopausal Females | 3.5 |
17 reviews available for melatonin and Menopause
| Article | Year |
|---|---|
Insomnia and menopause: a narrative review on mechanisms and treatments.
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Female; Hormone Replacement Therapy; Humans; Me | 2020 |
A practical nutritional guide for the management of sleep disturbances in menopause.
Topics: Adult; Aged; Anxiety; Depression; Diet; Female; Humans; Male; Melatonin; Menopause; Middle Aged; Obe | 2021 |
The Crosstalk between Melatonin and Sex Steroid Hormones.
Topics: Animals; Female; Gonadal Steroid Hormones; Gonads; Humans; Male; Melatonin; Menopause; Placenta; Pre | 2022 |
Effects of exogenous melatonin on sleep quality and menopausal symptoms in menopausal women: a systematic review and meta-analysis of randomized controlled trials.
Topics: China; Female; Humans; Melatonin; Menopause; Randomized Controlled Trials as Topic; Sleep | 2021 |
Melatonin and the health of menopausal women: A systematic review.
Topics: Bone Density; Female; Humans; Melatonin; Menopause; Sleep | 2021 |
Melatonin and female reproduction.
Topics: Animals; Circadian Rhythm; Female; Genitalia, Female; Humans; Melatonin; Menopause; Oogenesis; Ovula | 2014 |
Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures.
Topics: Animals; Bone Diseases, Metabolic; Bone Transplantation; Humans; Melatonin; Menopause; Mice; Osteobl | 2014 |
Melatonin in aging women.
Topics: Aging; Animals; Carbohydrate Metabolism; Female; Humans; Lipid Metabolism; Melatonin; Menopause; Neo | 2015 |
Circadian rhythm and menopause.
Topics: Aging; Circadian Rhythm; Female; Hot Flashes; Humans; Melatonin; Menopause; Middle Aged; Sex Charact | 2016 |
Sleep, rhythms and women's mood. Part II. Menopause.
Topics: Adult; Circadian Rhythm; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Hydrocortisone; M | 2006 |
Menopause related sleep disorders.
Topics: Depression; Estrogen Replacement Therapy; Estrogens; Female; Fibromyalgia; Humans; Hydrocortisone; M | 2005 |
[The influence of melatonin on human reproduction].
Topics: Animals; Circadian Rhythm; Female; Gonadotropin-Releasing Hormone; Gonads; Humans; Hypothalamus; Mal | 2007 |
Melatonin and human reproduction.
Topics: Adult; Animals; Circadian Rhythm; Female; Humans; Male; Melatonin; Menopause; Middle Aged; Pineal Gl | 1998 |
Industrialization, electromagnetic fields, and breast cancer risk.
Topics: Breast Neoplasms; Dose-Response Relationship, Radiation; Electromagnetic Fields; Female; Humans; Mal | 1999 |
Chronobiological basis of female-specific mood disorders.
Topics: Antidepressive Agents, Second-Generation; Chronobiology Phenomena; Cross-Over Studies; Depression, P | 2001 |
Melatonin deficiencies in women.
Topics: Breast Neoplasms; Circadian Rhythm; Depression; Female; Humans; Jet Lag Syndrome; Melatonin; Menopau | 2002 |
[Certain results and perspectives of the study of the role of the epiphysis in obstetrics and gynecology (literature survey)].
Topics: Female; Humans; Hypogonadism; Labor, Obstetric; Lactation; Melatonin; Menopause; Menstruation; Ovari | 1974 |
6 trials available for melatonin and Menopause
| Article | Year |
|---|---|
Myo-inositol and melatonin in the menopausal transition.
Topics: Body Mass Index; Dietary Supplements; Female; Humans; Inositol; Insulin; Melatonin; Menopause; Middl | 2017 |
Melatonin pharmacokinetics in premenopausal and postmenopausal healthy female volunteers.
Topics: Administration, Oral; Adult; Age Factors; Analysis of Variance; Area Under Curve; Body Mass Index; C | 2008 |
The effect of estradiol on the production of melatonin in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Estradiol; Estrogens; Female; Humans; Melato | 1995 |
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement.
Topics: Catecholamines; Cold Temperature; Double-Blind Method; Epinephrine; Estradiol; Estrogen Replacement | 2000 |
Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study.
Topics: Adult; Affect; Circadian Rhythm; Depression; Double-Blind Method; Female; Follicle Stimulating Hormo | 2001 |
Chronobiological basis of female-specific mood disorders.
Topics: Antidepressive Agents, Second-Generation; Chronobiology Phenomena; Cross-Over Studies; Depression, P | 2001 |
35 other studies available for melatonin and Menopause
| Article | Year |
|---|---|
[Perimenopausal melatonin deficiency syndrome in system of personalized management of quality of life of women with climacteric syndrome.]
Topics: Adult; Climacteric; Female; Humans; Melatonin; Menopause; Middle Aged; Perimenopause; Precision Medi | 2019 |
[Algorithm for stratification of women for differentiated therapy of menopausal syndrome in combination with perimenopausal melatonin deficiency syndrome.]
Topics: Algorithms; Female; Humans; Melatonin; Menopause; Perimenopause; Postmenopause; Quality of Life | 2020 |
Association of the melatonin circadian rhythms with clock 3111T/C gene polymorphism in Caucasian and Asian menopausal women with insomnia.
Topics: Asian People; Circadian Rhythm; CLOCK Proteins; Female; Gene Frequency; Genetic Predisposition to Di | 2018 |
Association of 3111T/C Polymorphism of the Clock Gene with Circadian Rhythm of Melatonin in Menopausal Women with Insomnia.
Topics: Alleles; Case-Control Studies; Circadian Rhythm; CLOCK Proteins; Female; Gene Expression Regulation; | 2018 |
Rotating night shift work and menopausal age.
Topics: Adult; Age Factors; Circadian Rhythm; Female; Humans; Melatonin; Menopause; Menstrual Cycle; Multiva | 2019 |
Sleep disturbances and changes in urinary 6-sulphatoxymelatonin levels in patients with breast cancer undergoing lumpectomy.
Topics: Adult; Aged; Anesthesia, General; Breast Neoplasms; Fatigue; Female; Humans; Mastectomy, Segmental; | 2013 |
The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice.
Topics: Animals; Aromatase; Drug Interactions; Estradiol; Estrogen Receptor alpha; Estrous Cycle; Female; Ge | 2014 |
Role of melatonin in circadian rhythm at menopause.
Topics: Circadian Rhythm; Female; Humans; Melatonin; Menopause | 2017 |
Improvement of leucocyte functions in ovariectomised aged rats after treatment with growth hormone, melatonin, oestrogens or phyto-oestrogens.
Topics: Age Factors; Aging; Animals; Cell Proliferation; Chemotaxis; Concanavalin A; Cytotoxicity, Immunolog | 2009 |
Relationship of morningness-eveningness questionnaire score to melatonin and sleep timing, body mass index and atypical depressive symptoms in peri- and post-menopausal women.
Topics: Analysis of Variance; Body Mass Index; Circadian Rhythm; Depression; Female; Humans; Melatonin; Meno | 2011 |
[Intrinsic skin aging. A critical appraisal of the role of hormones].
Topics: Administration, Topical; Adolescent; Adult; Age Factors; Aged; Androgens; Antioxidants; Chemexfoliat | 2003 |
Melatonin and breast cancer: a prospective study.
Topics: Adult; Aged; Breast Neoplasms; Case-Control Studies; Female; Humans; Matched-Pair Analysis; Melatoni | 2004 |
Interactions between melatonin and estrogen may regulate cerebrovascular function in women: clinical implications for the effective use of HRT during menopause and aging.
Topics: Cerebrovascular Circulation; Estrogen Replacement Therapy; Estrogens; Female; Humans; Melatonin; Men | 2005 |
Which alternative treatments work?
Topics: Back Pain; Chiropractic; Chondroitin; Cimicifuga; Complementary Therapies; Dietary Supplements; Echi | 2005 |
Effect of menopause on melatonin and alertness rhythms investigated in constant routine conditions.
Topics: Adult; Circadian Rhythm; Female; Habits; Humans; Melatonin; Menopause; Middle Aged; Postmenopause; P | 2005 |
Effects of melatonin in perimenopausal and menopausal women: our personal experience.
Topics: Adult; Animals; Estrogens; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Melato | 2005 |
Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels.
Topics: Adult; Age Factors; Body Mass Index; Exercise; Female; Gonadal Steroid Hormones; Humans; Life Style; | 2006 |
Urinary 6-sulfatoxymelatonin and mammographic density in Japanese women.
Topics: Adult; Breast Neoplasms; Cross-Sectional Studies; Female; Humans; Japan; Mammography; Melatonin; Men | 2007 |
Increased melatonin and delayed offset in menopausal depression: role of years past menopause, follicle-stimulating hormone, sleep end time, and body mass index.
Topics: Body Mass Index; Circadian Rhythm; Depressive Disorder; Estradiol; Female; Follicle Stimulating Horm | 2008 |
[Menopause--a key aspect of aging: role of the pineal gland].
Topics: Adolescent; Adult; Aging; Female; Humans; Magnetic Resonance Imaging; Male; Melatonin; Menopause; Mi | 2007 |
[The role of melatonin in regulation of gonadal function and its use in the treatment of pathological climax symptoms].
Topics: Adult; Catecholamines; Female; Hormones; Humans; Hypothalamo-Hypophyseal System; Lipids; Melatonin; | 2007 |
Suppression of basal luteinizing hormone concentrations by melatonin in postmenopausal women.
Topics: Female; Humans; Hypothalamo-Hypophyseal System; Infusions, Parenteral; Luteinizing Hormone; Melatoni | 1984 |
Radioimmunoassay for melatonin.
Topics: Adult; Animals; Female; Humans; Male; Melatonin; Menopause; Middle Aged; Neoplasms; Rabbits; Radioim | 1980 |
[Rejuvenating hormones].
Topics: Antioxidants; Climacteric; Dehydroepiandrosterone; Estrogen Replacement Therapy; Female; Free Radica | 1999 |
A role for melatonin in breast disease and the menopause.
Topics: Adult; Aged; Aged, 80 and over; Breast Diseases; Case-Control Studies; Female; Humans; Melatonin; Me | 2001 |
Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Alcohol Drinking; Body Mass Index; Breast Neo | 2001 |
Pineal gland, F.S.H., and breast-cancer aetiology.
Topics: Aged; Breast Neoplasms; Estrone; Female; Follicle Stimulating Hormone; Humans; Melatonin; Menopause; | 1978 |
Circadian variation in urinary melatonin in clinically healthy women in Japan and the United States of America.
Topics: Adult; Circadian Rhythm; Female; Humans; Japan; Melatonin; Menopause; Middle Aged; Statistics as Top | 1979 |
Effect of melatonin on the basal and stimulated gonadotropin levels in normal men and postmenopausal women.
Topics: Adult; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hor | 1976 |
[The gonadotropic hypothalamus. Its development from the embryonic period to the menopause].
Topics: Adolescent; Adult; Dopamine; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing | 1976 |
Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects.
Topics: Adult; Aged; Bipolar Disorder; Circadian Rhythm; Cross-Sectional Studies; Depressive Disorder; Dexam | 1992 |
Plasma melatonin in patients with breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Melatonin; Menopause; Middle Aged; Neoplasm Met | 1990 |
Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women.
Topics: Adult; Female; Gonadal Steroid Hormones; Humans; Melatonin; Menopause; Menstrual Cycle; Middle Aged; | 1990 |
6-sulphatoxymelatonin production in breast cancer patients.
Topics: Adult; Aged; Aging; Analysis of Variance; Biopsy; Breast Neoplasms; Circadian Rhythm; Female; Humans | 1990 |
Plasma melatonin and the hormone-dependency of human breast cancer.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Circadian Rhythm; Female; Humans; Melatonin; Menopause; M | 1985 |